The average price target of $25.78, which is higher than the current price of $23.851, indicates a potential upside for Immunovant's stock. Additionally, the average price target has increased by 5.22% over the past month, showing growing optimism among analysts. This positive sentiment is likely to have a short-term positive impact on IMVT's stock price.